At AAN 2017, Robert Zivadinov, MD, PhD, Professor of neurology, University at Buffalo, discussed the primary findings in the phase 3 randomized, placebo controlled TOPIC study, which focused really on the differences between the two doses (7 and 14mg) of Aubagio and placebo. 

The Effect of Disease Modifying Treatment In Multiple Sclerosis Patients



At AAN 2017, Robert Zivadinov, MD, PhD, Professor of neurology, University at Buffalo, discussed the primary findings in the phase 3 randomized, placebo controlled TOPIC study, which focused really on the differences between the two doses (7 and 14mg) of Aubagio and placebo. 
Episode 1 Multiple Sclerosis AAN Video Highlights
Episode 2 Tardive Dyskinesia AAN Video Highlights
Episode 3 Novel Alzheimer's disease Therapy to Slow Cognitive Decline?
Episode 4 The Unmet Needs in ALS Research: Diagnose, Treat Patients Earlier
Episode 5 What Are New Developments in Epilepsy Research?
Episode 6 Advancing Innovative Technology into Safe and Effective Medicines
Episode 7 Transforming The Approach to Epilepsy Treatment
Episode 8 The Effect of Disease Modifying Treatment In Multiple Sclerosis Patients
Episode 9 Treating Cluster Headaches with Non-Invasive Vagal Nerve Stimulator
Episode 10 Multiple Sclerosis: The Impact on Cortical Atrophy

Latest Peer Exchange

Multiple Sclerosis: The Impact on Cortical Atrophy
Multiple Sclerosis: The Impact on Cortical Atrophy
Treating Cluster Headaches with Non-Invasive Vagal Nerve Stimulator
Treating Cluster Headaches with Non-Invasive Vagal Nerve Stimulator
The Effect of Disease Modifying Treatment In Multiple Sclerosis Patients
The Effect of Disease Modifying Treatment In Multiple Sclerosis Patients
Transforming The Approach to Epilepsy Treatment
Transforming The Approach to Epilepsy Treatment
Advancing Innovative Technology into Safe and Effective Medicines
Advancing Innovative Technology into Safe and Effective Medicines
What Are New Developments in Epilepsy Research?
What Are New Developments in Epilepsy Research?
The Unmet Needs in ALS Research: Diagnose, Treat Patients Earlier
The Unmet Needs in ALS Research: Diagnose, Treat Patients Earlier
Novel Alzheimer's disease Therapy to Slow Cognitive Decline?
Novel Alzheimer's disease Therapy to Slow Cognitive Decline?
Tardive Dyskinesia AAN Video Highlights
Tardive Dyskinesia AAN Video Highlights
Multiple Sclerosis AAN Video Highlights
Multiple Sclerosis AAN Video Highlights

Most Popular

@MDMagazine

$vAR$